Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biotechnology Companies in 2024
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.
  1. Adimmune Corporation

    World Rank (Jan-05-2024)
    13,256
    Market Cap (Jan-05-2024)
    0.450 Billion USD
    World Rank (Jul-30-2023)
    13,069
    Market Cap (Jul-30-2023)
    0.474 Billion USD
    World Rank (Dec-25-2022)
    12,394
    Market Cap (Dec-25-2022)
    0.500 Billion USD
    World Rank (Jan-07-2022)
    11,424
    Market Cap (Jan-07-2022)
    0.70 Billion USD
    Annual Revenue in USD
    54 Million USD
    Annual Net Income in USD
    1 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  2. Cullinan Oncology Inc.

    World Rank (Jan-05-2024)
    13,291
    Market Cap (Jan-05-2024)
    0.447 Billion USD
    World Rank (Jul-30-2023)
    14,109
    Market Cap (Jul-30-2023)
    0.401 Billion USD
    World Rank (Dec-25-2022)
    12,838
    Market Cap (Dec-25-2022)
    0.469 Billion USD
    World Rank (Jan-07-2022)
    11,894
    Market Cap (Jan-07-2022)
    0.64 Billion USD
    Annual Revenue in USD
    18 Million USD
    Annual Net Income in USD
    -65 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  3. MeiraGTx Holdings

    World Rank (Jan-05-2024)
    13,314
    Market Cap (Jan-05-2024)
    0.446 Billion USD
    World Rank (Jul-30-2023)
    14,767
    Market Cap (Jul-30-2023)
    0.362 Billion USD
    World Rank (Dec-25-2022)
    16,414
    Market Cap (Dec-25-2022)
    0.269 Billion USD
    World Rank (Jan-07-2022)
    9,687
    Market Cap (Jan-07-2022)
    0.96 Billion USD
    Annual Revenue in USD
    37 Million USD
    Annual Net Income in USD
    -79 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    MeiraGTx Holdings is a Clinical Stage Gene Therapy company. It is focused on developing potentially curative treatments for patients living with serious diseases. The company annual revenue is 5.1 million USD and 155 full employees as on 2019. The headquarters is in USA.
  4. Carsgen Therapeutics Holdings Limited

    World Rank (Jan-05-2024)
    13,344
    Market Cap (Jan-05-2024)
    0.444 Billion USD
    World Rank (Jul-30-2023)
    9,695
    Market Cap (Jul-30-2023)
    0.833 Billion USD
    World Rank (Dec-25-2022)
    8,187
    Market Cap (Dec-25-2022)
    1.039 Billion USD
    World Rank (Jan-07-2022)
    6,884
    Market Cap (Jan-07-2022)
    1.72 Billion USD
    Headquarters Country
  5. Aura Biosciences Inc.

    World Rank (Jan-05-2024)
    13,348
    Market Cap (Jan-05-2024)
    0.443 Billion USD
    World Rank (Jul-30-2023)
    13,486
    Market Cap (Jul-30-2023)
    0.445 Billion USD
    World Rank (Dec-25-2022)
    13,819
    Market Cap (Dec-25-2022)
    0.403 Billion USD
    World Rank (Jan-07-2022)
    13,547
    Market Cap (Jan-07-2022)
    0.50 Billion USD
    Annual Net Income in USD
    -46 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  6. AC Immune SA

    World Rank (Jan-05-2024)
    13,356
    Market Cap (Jan-05-2024)
    0.443 Billion USD
    World Rank (Jul-30-2023)
    17,083
    Market Cap (Jul-30-2023)
    0.240 Billion USD
    World Rank (Dec-25-2022)
    19,687
    Market Cap (Dec-25-2022)
    0.146 Billion USD
    World Rank (Jan-07-2022)
    15,664
    Market Cap (Jan-07-2022)
    0.35 Billion USD
    Annual Revenue in USD
    18 Million USD
    Annual Net Income in USD
    -71 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  7. Lifecome Biochemistry

    World Rank (Jan-05-2024)
    13,379
    Market Cap (Jan-05-2024)
    0.441 Billion USD
    World Rank (Jul-30-2023)
    10,540
    Market Cap (Jul-30-2023)
    0.717 Billion USD
    World Rank (Dec-25-2022)
    8,214
    Market Cap (Dec-25-2022)
    1.032 Billion USD
    World Rank (Jan-07-2022)
    17,405
    Market Cap (Jan-07-2022)
    0.27 Billion USD
    Headquarters Country
  8. Idorsia Ltd

    World Rank (Jan-05-2024)
    13,426
    Market Cap (Jan-05-2024)
    0.438 Billion USD
    World Rank (Jul-30-2023)
    7,285
    Market Cap (Jul-30-2023)
    1.359 Billion USD
    World Rank (Dec-25-2022)
    4,517
    Market Cap (Dec-25-2022)
    2.630 Billion USD
    World Rank (Jan-07-2022)
    4,316
    Market Cap (Jan-07-2022)
    3.53 Billion USD
    Annual Revenue in USD
    37 Million USD
    Annual Net Income in USD
    -678 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Idorsia Ltd is the leading Biopharmaceutical company specialized in the discovery, development and commercialization of innovative small molecules with the aim of transforming the horizon of therapeutic options. The headquarters is in Switzerland.
    Facts About Company
    The company annual revenue was 97 million CHF and annual net loss was -827 million CHF for year ending Dec-2022.
  9. Intercept Pharmaceuticals

    World Rank (Jan-05-2024)
    13,459
    World Rank (Jul-30-2023)
    13,459
    Market Cap (Jul-30-2023)
    0.447 Billion USD
    World Rank (Dec-25-2022)
    12,555
    Market Cap (Dec-25-2022)
    0.490 Billion USD
    World Rank (Jan-07-2022)
    14,284
    Market Cap (Jan-07-2022)
    0.44 Billion USD
    Annual Revenue in USD
    313 Million USD
    Annual Net Income in USD
    -275 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    Intercept Pharmaceuticals is a biotechnology sector company. The headquarters is in USA.

  10. Urogen Pharma

    World Rank (Jan-05-2024)
    13,467
    Market Cap (Jan-05-2024)
    0.435 Billion USD
    World Rank (Jul-30-2023)
    12,378
    Market Cap (Jul-30-2023)
    0.530 Billion USD
    World Rank (Dec-25-2022)
    18,356
    Market Cap (Dec-25-2022)
    0.188 Billion USD
    World Rank (Jan-07-2022)
    18,931
    Market Cap (Jan-07-2022)
    0.20 Billion USD
    Annual Revenue in USD
    64 Million USD
    Annual Operating Income in USD
    -79 Million USD
    Annual Net Income in USD
    -109 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    UroGen Pharma is a Biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. The company annual revenue is 3.5 million USD and 156 employees as on 2020. The headquarters is in USA.

Share

Ads